DHINGRA, KAPIL,HIGGINS, BRIAN,KOLINSKY, KENNETH,LEE, RICHARD J.,LESTINI, BRIAN,PACKMAN, KATHRYN E.,SU, FEI
申请号:
SG2013010640
公开号:
SG188207A1
申请日:
2011.08.16
申请国别(地区):
SG
年份:
2013
代理人:
摘要:
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4- chloro-phenyl)-1H-pyrrolo [2,3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.